| 标题 |
[求助补充材料]
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Nicholas D. James; Nicholas D. James; M. Sydes; N. Clarke; M. Mason; et al 出版日期:2016-03-19 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)